BerGenBio shares soar on COVID-19 drug trial news

Shares of Norway's BerGenBio more than doubled on Wednesday after a cancer drug it is developing was selected for a British trial of potential COVID-19 treatments, the latest instance of a firm seeking to re-purpose a medicine to fight the pandemic.